Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$23,567,868
+$8,525,001 QoQ
Shares Held
108,363
+64.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 93.57898913835903.ToString("F0")%
Shared 0.ToString("F0")%
None 6.4210108616409665.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL SARL holds $415,680,689 across 10 Drug Manufacturers - General names. ABBV ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
914,752 | $180,407,389 | |
| 2 | LLY |
ELI LILLY & Co
|
150,461 | $138,389,513 | |
| 3 | AMGN |
Amgen Inc
|
94,516 | $33,255,454 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
108,363 | $23,567,868 | |
| 5 | PFE |
Pfizer Inc
|
759,368 | $21,323,053 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,231 | $5,715,110 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
40,000 | $5,574,800 | |
| 8 | GRFS |
Grifols SA
|
645,251 | $5,174,913 |
All Filings in ABBV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,567,868 | 108,363 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $15,042,867 | 65,836 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $9,387,094 | 40,542 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,715,295 | 41,565 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $11,480,438 | 54,794 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $14,948,301 | 84,121 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $16,553,168 | 83,822 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,749,729 | 80,164 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,567,906 | 74,508 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,683,503 | 30,222 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,376,252 | 29,359 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,661,523 | 34,599 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,476,909 | 34,366 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,321,085 | 20,550 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,349,748 | 17,508 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,203,819 | 14,389 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,934,191 | 18,100 | Shares | Defined | 2022-05-19 | |
| No filing history on record for this holder in this stock. | ||||||